Criteria & Principles
Rapid molecular diagnostic technologies for infectious diseases have dramatically reduced the time to pathogen identification thus allowing for earlier ‘targeting’ of therapy to the most effective agent.
BioFire Blood Culture Identification Panel 2 (BCID2): DUH Raleigh Campus Guideline for Management of Positive Blood Cultures
- Available on-site at DUH Raleigh Campus microbiology lab
- Identifies 43 molecular targets on a limited list of pathogens that commonly cause bacteremia (eg, MRSA, Candida albicans, E. coli), including multiple resistance genes (i.e., KPC, mecA/C and MREJ, vanA/B)
- Turnaround time is approximataly 1 hour after positive Gram stain from a blood sample.
Please contact the DUH Raleigh Campus Antimicrobial Stewardship Team Pharmacist (919-485-1736) with questions.
Diagnosis-Specific Information
Table 1. Resistance Genes from BCID2 and Interpretation
Table 2. YEAST Empiric Treatment Recommendations
Table 3. GRAM POSITIVE Organism Empiric Treatment Recommendations
Table 4. GRAM NEGATIVE Organism Empiric Treatment Recommendations
